A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patientswith advanced multiple myeloma
Matthias Obenaus, Antonio Pezzutto, Martin Vaegler, Jan Krönke et al.
Journal
Haematologica
Topics
CAR-T cell therapy research
article
A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patientswith advanced multiple myeloma
Matthias Obenaus, Antonio Pezzutto, Martin Vaegler, Jan Krönke, Ulrich Bernd Keller, Thomas J. F. Blankenstein, Dana Hoser, Ann‐Christin von Brünneck, Vivian Scheuplein, Korinna Jöhrens, Igor Wolfgang Blau, Gerald Willimsky, Elisa Kieback, Axel Nogai, Josefine Krüger, Antonia Busse, Ioannis Anagnostopoulos, Hana Rauschenbach, Judith Böhme
article en
Abstract
No abstract available for this paper.
Publication Tag
HaematologicaVol. 110(1)
Institutions
Max Delbrück Center (DE), Heidelberg University (DE), Humboldt-Universität zu Berlin (DE), German Cancer Society (DE), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), Charité - Universitätsmedizin Berlin (DE)
Funders
Bundesministerium für Bildung und Forschung, Medizinischen Hochschule Hannover
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patientswith advanced multiple myeloma — Matthias Obenaus, Antonio Pezzutto, et al. · Haematologica (2024) | TGRS Research Map | TGRS